BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 808405)

  • 21. [Comparison of glibenclamide, gliquidone, glisoxepide and placebo in maturity onset diabetics of differing degrees of severity (author's transl)].
    Irsigler K; Ogris E; Steinhardt T; Brändle J; Regal H; Zdolsek I
    Wien Klin Wochenschr; 1979 Aug; 91(16):541-50. PubMed ID: 115159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glibenclamide and gliquidone in the treatment of non-insulin-dependent diabetes mellitus.
    Nikkilä K; Groop L
    Acta Med Scand; 1982; 211(1-2):13-7. PubMed ID: 6803519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanism of the antidiabetic action of sulfanylurea derivatives].
    Iaroshevskiĭ IuA; Volkova EA
    Klin Med (Mosk); 1982 Oct; 60(10):94-7. PubMed ID: 6757562
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin and oral hypoglycemic agents.
    Price MJ
    Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
    [No Abstract]   [Full Text] [Related]  

  • 25. Diabetic control with gliquidone--a short acting sulphonylurea.
    Borthwick LJ; Wilson S
    Eur J Clin Pharmacol; 1984; 26(4):475-9. PubMed ID: 6428917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus.
    Loomba-Albrecht LA; Glaser NS; Styne DM; Bremer AA
    Clin Ther; 2009 Apr; 31(4):816-20. PubMed ID: 19446154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined therapy with insulin/gliquidone (Glurenorm) in type 2 diabetes after treatment failure using oral antidiabetic agents].
    Podrouzková B; Krusová D
    Vnitr Lek; 1992 Oct; 38(10):963-7. PubMed ID: 1481374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical evaluation of an oral antidiabetic drug.
    Müller R
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:39-46. PubMed ID: 5005130
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I; Madsen SN
    Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
    [No Abstract]   [Full Text] [Related]  

  • 30. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 31. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H; Denes A; Girard J; Collard F; Berger W
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide].
    Rupprecht E; König E; Limmer J
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():31-2. PubMed ID: 8516203
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.
    Bonora E; Moghetti P; Querena M; Zenere M; Cacciatori V; Tosi F; Travia D; Zoppini G; Muggeo M
    J Endocrinol Invest; 1992 Jan; 15(1):1-11. PubMed ID: 1560186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E; Beyer J; Schöffling K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
    [No Abstract]   [Full Text] [Related]  

  • 35. Controlling diabetes with diet and oral hypoglycemic agents.
    Faludi G
    Geriatrics; 1976 Oct; 31(10):67-70. PubMed ID: 964602
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral hypoglycemic drugs for gestational diabetes.
    Greene MF
    N Engl J Med; 2000 Oct; 343(16):1178-9. PubMed ID: 11036125
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of the hypoglycaemic and antilipolytic effects of four antidiabetic agents administered i.v.
    Guirgis FK; Ghanem MH; Abdel-Hay MM
    Arzneimittelforschung; 1976; 26(3):435-7. PubMed ID: 134717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental and clinical pharmacology of oral antidiabetics].
    Cuomo V; Marino A
    Clin Ter; 1972 Sep; 62(6):505-52. PubMed ID: 4674507
    [No Abstract]   [Full Text] [Related]  

  • 40. [Oral hypoglycemic therapy of diabetes mellitus].
    Montenero P
    Minerva Med; 1976 Jan; 67(3):208-15. PubMed ID: 1250219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.